(1) The primary symptoms were hypogonadism (libido loss, erectile dysfunction, gynecomastia), with mildly elevated prolactin levels that responded well to dopamine agonist therapy; the hypogonadism symptoms improved concurrently with the reduction in prolactin. The gene discussed is PRL; the disease is Gynecomastia.